ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 2.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $6,339,000 | -15.2% | 509,592 | -6.7% | 0.01% | 0.0% |
Q3 2016 | $7,479,000 | +75.5% | 546,300 | -5.3% | 0.01% | +66.7% |
Q2 2016 | $4,262,000 | +19.1% | 576,678 | +3.0% | 0.00% | 0.0% |
Q1 2016 | $3,579,000 | -13.3% | 560,139 | -15.2% | 0.00% | 0.0% |
Q4 2015 | $4,128,000 | -5.2% | 660,509 | -11.4% | 0.00% | 0.0% |
Q3 2015 | $4,354,000 | -35.7% | 745,633 | -8.9% | 0.00% | -40.0% |
Q2 2015 | $6,770,000 | +1.9% | 818,604 | +1.5% | 0.01% | 0.0% |
Q1 2015 | $6,646,000 | +20.3% | 806,573 | +0.3% | 0.01% | +25.0% |
Q4 2014 | $5,526,000 | +21.2% | 804,399 | -4.7% | 0.00% | +33.3% |
Q3 2014 | $4,559,000 | -17.9% | 844,321 | -3.2% | 0.00% | -25.0% |
Q2 2014 | $5,553,000 | +141.5% | 871,817 | +205.6% | 0.00% | +100.0% |
Q1 2014 | $2,299,000 | +1170.2% | 285,269 | +976.5% | 0.00% | – |
Q4 2013 | $181,000 | -99.1% | 26,499 | -97.4% | 0.00% | -100.0% |
Q3 2013 | $19,093,000 | -17.3% | 1,037,689 | -21.4% | 0.02% | -21.1% |
Q2 2013 | $23,077,000 | – | 1,319,435 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
Geduld E E | 272,200 | $1,470,000 | 1.04% |
Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |